1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine(CAS: 670220-88-9)

1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine (CAS: 670220-88-9) falls under the scope of the REACH Regulation in the European Union. It may also require classification and labeling under the GHS (Globally Harmonized System of Classification and Labeling of Chemicals). In the US, it would need to comply with FDA requirements for chemical substances and the EPA for environmental and safety regulations.

For the synthesis of 1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine (CAS: 670220-88-9), alternative reagents such as related piperidines, benzimidazoles, and quinolines can be considered. Isomers and analogs like 1-(2-{5-[(3-Ethyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine may also serve as viable alternatives based on the specific synthetic route and desired properties.

The research trend for 1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine (CAS: 670220-88-9) indicates growing interest in its potential applications in pharmaceuticals and medicinal chemistry. Market trends suggest increasing demand due to its unique chemical structure and pharmacological activity. Emerging research focuses on its use as a potential therapeutic agent for various diseases, such as cancer and neurodegenerative disorders.

Waste containing 1-(2-{5-[(3-Methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl}-8-quinolinyl)-4-piperidinamine (CAS: 670220-88-9) should be collected in appropriate containers and disposed of by incineration or professional waste disposal services. Environmental protection measures include proper labeling of waste containers, adherence to local waste disposal regulations, and monitoring of environmental impact to ensure compliance with regulatory standards and safety guidelines.